Related Experiment Video
Updated: Apr 28, 2026
Structural Biology and Analytical Chemistry Approaches for Characterizing C-Glycoside Metabolic Enzymes in Human Gut Microbiota
Published on: May 23, 2025
Determination of DPYD enzyme activity in Korean population
Joong-Gon Shin1, Tae Sun Kang, Hyun Sub Cheong
1*Department of Life Science, Sogang University, Seoul; †Division of Clinical Research, Department of Toxicological Evaluation and Research, National Institute of Food and Drug Safety Evaluation, Chungcheongbuk-do; and ‡Department of Genetic Epidemiology, SNP Genetics, Inc, Seoul, Korea.
Background:
Dihydropyrimidine dehydrogenase (DPYD) is an enzyme that regulates the rate-limiting step in pyrimidine metabolism, especially catabolism of fluorouracil. This study was performed to analyze the association between DPYD genetic variants and DPYD enzyme activity in the Korean population.
Methods:
We screened the genetic variants and analyzed the enzyme activity in 73 healthy Korean subjects (69 men and 4 women; mean age, 22.6 years). Direct sequencing was conducted using the ABI 3730XL system, and enzyme activity was determined using high-performance liquid chromatography.
Results:
A total of 83 genetic variants were observed. Among the identified genetic variants, 32 were polymorphic including 3 core and 11 novel genetic variants. Association analysis between each genetic variant and enzyme activity in Korean subjects showed that 2 novel genetic variants, -832 G>A and -131 C>A, induced a significant difference in enzyme activity (P < 0.05).
Conclusions:
To our knowledge, this is the first study that has examined the association between enzyme activity and DPYD genetic variants in the Korean population. In this study, we identified novel genetic variants that are associated with the enzyme activity. These findings will be valuable for further pharmacogenetic studies and especially useful for personalized medicine.
